Randomised, double blind, placebo controlled comparison of ginkgo biloba and acetazolamide for prevention of acute mountain sickness among Himalayan trekkers: the prevention of high altitude illness trial (PHAIT)
Objective To evaluate the efficacy of ginkgo biloba, acetazolamide, and their combination as prophylaxis against acute mountain sickness. Design Prospective, double blind, randomised, placebo controlled trial. Setting Approach to Mount Everest base camp in the Nepal Himalayas at 4280 m or 4358 m and...
Enregistré dans:
| Publié dans: | BMJ |
|---|---|
| Auteurs principaux: | , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2004
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC383373/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/15070635/ https://ncbi.nlm.nih.govhttps://doi.org/10.1136/bmj.38043.501690.7C |
| Tags: |
Pas de tags, Soyez le premier à ajouter un tag!
|